Page last updated: 2024-11-01

nitrazepam and Cardiomyopathies

nitrazepam has been researched along with Cardiomyopathies in 1 studies

Nitrazepam: A benzodiazepine derivative used as an anticonvulsant and hypnotic.
nitrazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome).

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamijo, Y1
Sato, C1
Yoshimura, K1
Soma, K1

Other Studies

1 other study available for nitrazepam and Cardiomyopathies

ArticleYear
Notable pink excreta and severe myocardial suppression in superwarfarin (difethialone) intoxication.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:22

    Topics: 4-Hydroxycoumarins; Anticoagulants; Cardiomyopathies; Coloring Agents; Female; Humans; Intra-Aortic

2011